Skip to content

Role of Salix Fragalis in treatment of Cervical Spondylosis

Clinical Effectiveness of Salix Fragalis in Treatment of Cervical Spondylosis: A single arm clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067908
Enrollment
40
Registered
2024-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M45-M49- Spondylopathies

Interventions

Intervention1: Salix Fragilis: Salix Fragilis will be prescribed in Cervical spondylosis. Potency will be used from 30C to 1M. Medicine will be administrated by oral route. Follow up done in every 15

Sponsors

RBTS Govt Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to give consent to take part in study Patients having age group of 30 – 60yr Patients of both sex and all religion Patients are self-diagnosed and on previous treatment for cervical spondylosis Patient agree to go on further investigations, if required

Exclusion criteria

Exclusion criteria: Patient not willing to give consent to take part in study Patients having age group below 30yr and above 60yr Patients of other diseases of neck such as amyotrophic lateral sclerosis, multiple sclerosis, syringomyelia, cervical disc prolapse. Pregnancy and lactating mother

Design outcomes

Primary

MeasureTime frame
Scoring system to assess the quality of life in Cervical SpondylosisTimepoint: 3-4 month

Secondary

MeasureTime frame
36-Item Short-Form Health Survey (SF-36).Timepoint: 3-4 month

Countries

India

Contacts

Public ContactPranjal Kumar

R.B.T.S. Govt. Homoeopathic Medical College and Hospital

mkranjan06@gmail.com8210829686

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026